Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcoma (Q38460247)
Jump to navigation
Jump to search
scientific article published on 04 December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcoma |
scientific article published on 04 December 2012 |
Statements
1 reference
Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcoma (English)
1 reference
M M Mita
1 reference
E Poplin
1 reference
C D Britten
1 reference
W D Tap
1 reference
E H Rubin
1 reference
B B Scott
1 reference
L Berk
1 reference
V M Rivera
1 reference
J W Loewy
1 reference
P Dodion
1 reference
F Haluska
1 reference
J Sarantopoulos
1 reference
A Mita
1 reference
A Tolcher
1 reference
4 December 2012
1 reference
1 reference
24
1 reference
4
1 reference
1104-1111
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference